Clinical impact of thymosin alpha 1 as an adjuvant in enhancing frozen embryo transfer outcomes: a self-controlled study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20261458Keywords:
Thymosin alpha 1, Recurrent implantation failure, Frozen embryo transferAbstract
Background: Endometrial immune milieu when studied appeared to be dysregulated in 81.7% of women with recurrent implantation failure (RIF). Thymosin alpha 1, a small peptide secreted from the thymus gland has the ability to favourably alter the maternal immune milieu conducive for embryo implantation and maintenance of pregnancy. This study plans to evaluate the impact of empirical use of Thymosin alpha 1 as an adjuvant in improving the pregnancy outcomes in women with more than two failed frozen embryo transfers (FETs).
Methods: Women who experienced two prior failed FETs despite good-quality embryos underwent endometrial preparation for their next FET cycle using hormone replacement therapy (HRT) supplemented with exogenous Thymosin alpha 1. Pregnancy outcomes were then compared to those from the immediately preceding cycle.
Results: In this cohort of 27 patients with two prior FET failures, addition of Thymosin alpha 1 in the subsequent FET cycle significantly improved implantation rates (63.4%; p<0.001) biochemical and clinical pregnancy rates (66.7%; p<0.001), and ongoing pregnancy rates (59.3%; p<0.001). No significant difference was observed in mean Thymosin dose between pregnant and non-pregnant women (22 mg vs. 20.3 mg; p=0.373).
Conclusions: The study provides encouraging evidence that thymosin alpha 1 could be an useful adjunct for improving pregnancy outcomes in women with RIF.
References
Busnelli A, Reschini M, Cardellicchio L, Vegetti W, Somigliana E, Vercellini P. How common is real repeated implantation failure? An indirect estimate of the prevalence. Reprod Biomed Online. 2020;40(1):91 7.
Ali SB, Jeelani R, Ozimek N, Moodley J, Acharya S. The role of immunological testing and intervention in reproductive medicine: a guideline. Hum Reprod Open. 2018;2018(3):hoy007.
Lédée N, Petitbarat M, Chevrier L, Vitoux D, Vezmar K, Rahmati M, et al. The uterine immune profile may help women with repeated unexplained embryo implantation failure after in vitro fertilization. Am J Reprod Immunol. 2016;75(4):388-401.
Bashiri A, Halper KI, Orvieto R. Recurrent implantation failure: update overview on etiology, diagnosis, treatment and future directions. Reprod Biol Endocrinol. 2018;16:121.
Raghupathy R, Kalinka J. Cytokine imbalance in pregnancy complications and its modulation. Front Biosci. 2008;13:985 94.
Zhang Y, Wang Y, Li MQ, Duan J, Fan DX, Jin LP, et al. IL 25 promotes Th2 bias by upregulating IL 4 and IL 10 expression of decidual γδ T cells in early pregnancy. Exp Ther Med. 2018;15(2):1855 62.
Erlebacher A. Immunology of the maternal fetal interface. Annu Rev Immunol. 2013;31:387 411.
Guo L, Guo A, Yang F, Li L, Yan J, Deng X, et al. Alterations of cytokine profiles in patients with recurrent implantation failure. Front Endocrinol (Lausanne). 2022;13:949123.
Kwak Kim JY, Chung Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod. 2003;18(4):767 73.
Kaufmann RA, Welch RA, Mutchnick MG. Low periconceptional maternal serum thymosin alpha 1 levels are associated with blighted pregnancies. Am J Reprod Immunol. 1993;29(3):171 5.
Hirachan A, Bakshi R. Enhancing embryo implantation success: the role of alpha thymosin in modulating immune response in recurrent implantation failure. Res J Med Sci. 2024;18(6):306 10.
Wang Y, Tian Y, Liu L, Li TC, Tong X, Zhu H, et al. The number of previous failed embryo transfer cycles is an independent factor affecting implantation rate in women undergoing IVF/ICSI treatment: a retrospective cohort study. Medicine (Baltimore). 2021;100(9):e25034.
Rajan A, Sampath A, Supriya SM, Dhanasekaran RK. Successful pregnancy after administration of thymosin alpha 1 in a woman with recurrent implantation failure. Int J Pharm Clin Res. 2024;6(2):73 5.
Downloads
Published
How to Cite
Issue
Section
